Illness	Number of cases
Malignant neoplasm of bronchus and lung (C34.1)	60
Non-follicular lymphoma (C83.3)	52
Malignant neoplasm of bronchus and lung (C34.3)	50
Myeloid leukaemia - Acute myeloblastic leukemia not having achieved remission (C92.00)	46
Malignant neoplasm of bronchus and lung (C34.8)	26
Non-follicular lymphoma (C83.1)	22
Malignant neoplasm of pancreas - Malignant neoplasm of body of pancreas (C25.1)	19
Malignant neoplasm of pancreas - Malignant neoplasm of head of pancreas (C25.0)	17
Malignant neoplasm of nasopharynx - Malignant neoplasm of nasopharynx unspecified (C11.9)	16
Malignant neoplasm of stomach - Malignant neoplasm of cardia (C16.0)	16

Top 10 treatments

Treatment	Number
Others therapeutic procedures to influence the immune system (8-547.30)	201
(9-984.7)	160
Others therapeutic procedures to influence the immune system (8-547.0)	154
(9-984.8)	147
Transfusion of blood, red blood cells or platelets from a donor to a recipient (8-800.c0)	146
Administration of medicines in accordance with List 2 of the procedures list (6-002.72)	128
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.13)	108
Examination of the oesophagus, stomach and duodenum by endoscopy (1-632.0)	94
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.12)	77
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.11)	71

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0500

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Chronische obstruktive Lungenerkrankung (COPD)

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01
CQ25
CQ31

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
110	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
110	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
108	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities	Diverse Dozenturen/ Lehrbeauftragungen,
Lectureships / teaching posts at universities of applied sciences
Student training (clinical traineeship / internship year)	Lehrbeauftragte und apl. Professuren an der Universität Bochum Diverse Teilnahmen an projektbezogener Zusammenarbeit mit Hochschulen und Universitäten.
Project-related cooperation with colleges and universities	Prof. Dr. Szeimies: Promotionsgutachten Uni Witten-Herdecke, Med. Fakultät, Uni Kopenhagen, Med. Fakultät, Habilitationsgutachten Uni Chicago, Med. Fakultät.
Participation in multi-centre Phase I/II studies	Teilnahme an Leitlinienkonferenzen der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) Virushepatitis B und C sowie kolorektaler Karzinom
Participation in multi-centre phase III/IV studies	Prof. Dr. med. Stephan Klebe: Teilnahme Enrich AF (Hamilton Science)
Initiation and management of uni-centric/multi-centric clinical/scientific studies	Prof. Dr. med. Rolf-Markus Szeimies: nationale und internationale Studienleitung bei zwei uni- und multizentrischen Studien zur Behandlung von hellem Hautkrebs und Vorstufen
Editors of scientific journals/textbooks	Klinische Neurophysiologie Neurolab Prof. Dr. med. Rolf-Markus Szeimies: Herausgeber „Die Dermatologie“; Editorial Board „Photodermatology, Photoimmunology & Photomedicine“
Doctoral supervision	PD Dr. Reiser gem. mit Prof. Dr. Szeimies: Retrospektive Analyse der Ursachen einer Zostererkrankung am stationären Krankengut der Klinik für Dermatologie und Allergologie im Zeitraum von 2009-2019

Training

No.	Training in other healing professions	Comment
HB01	Nurse and health care worker (m/f)	Theoretische und praktische Ausbildung
HB03	Physical therapist / physiotherapist (m/f)	Praktische Ausbildung
HB05	Medical technical radiology assistant (MTRA) (m/f)	Theoretische und praktische Ausbildung
HB07	Surgical technical assistant (m/f)	Ausbildung
HB17	Auxiliary nurse (m/f)	Theoretische und praktische Ausbildung
HB15	Anaesthesia technical assistant (m/f)	Ausbildung
HB19	Nursing professionals	Theoretische und praktische Ausbildung
HB06	Occupational therapist (m/f)